Suitability of Measures of Pharmacy-Based Medication Adherence for Routine Clinical Use Among Patients with Chronic Diseases: A Systematic Review

Overview

Journal Patient Prefer Adherence

Date 2025 Feb 4

PMID 39901904

Authors

Wardatul Jannah

Qisty A Khoiry

Sofa D Alfian

Rizky Abdulah

Affiliations

Soon will be listed here.

Abstract

Purpose: To identify the suitability of pharmacy-based measures for determining medication adherence in routine clinical use.

Methods: Data were obtained through PubMed and Scopus databases up to December 2023 without publication year restrictions. This review included English studies on assessing medication adherence for hypertension, hyperlipidemia, asthma, chronic obstructive pulmonary disease, and diabetes, using pharmacy databases and providing full-text access. We investigated evidence quality utilizing the Newcastle-Ottawa Scale for non-randomized studies (cohort, case-control, and cross-sectional) and the Risk of Bias Assessment Tool for Non-randomized Studies-2 and JADAD scales for quasi-experiments and randomized control trials, respectively. We determined validity characteristics (completeness, accuracy, reliability, objectivity, continuous adherence history, non-intrusiveness, sensitivity, and specificity) and applicability (cost-effectiveness, ease of use, and interpretability) to evaluate the suitability of pharmacy-based medication adherence measures in clinical settings.

Results: This review retrieved 1513 studies, of which 74 met the inclusion criteria. All of the studies, which were published from 2000 to 2023 and mostly utilized a retrospective cohort design (n = 53), included 17.6 million patients. Of the 74 studies, 50 were conducted in the United States. Diabetes mellitus (n = 40) was the most prevalent disease, whereas the medication possession ratio (n = 46) and prescription days covered (n = 31) were the most prevalent pharmacy-based matrix. According to the results, 73 articles demonstrated validity characteristics, whereas 1 article lacked these characteristics. All 74 (100%) articles had applicability characteristics.

Conclusion: This systematic review demonstrates that pharmacy-based measures possess valid characteristics, including comprehensive, accurate, objective, reliable, and continuously updated adherence history records. These measures are designed to minimize disruption while offering high sensitivity and specificity. Furthermore, they are characterized by their practicality, being cost-effective, easy to implement, and easy to interpret. These findings suggest that pharmacy-based measures are potentially suitable to assess medication adherence for routine clinical use.

References

Jentzsch N, Camargos P, Colosimo E, Bousquet J . Monitoring adherence to beclomethasone in asthmatic children and adolescents through four different methods. Allergy. 2009; 64(10):1458-1462. DOI: 10.1111/j.1398-9995.2009.02037.x. View

Bender B, Cvietusa P, Goodrich G, Lowe R, Nuanes H, Rand C . Pragmatic trial of health care technologies to improve adherence to pediatric asthma treatment: a randomized clinical trial. JAMA Pediatr. 2015; 169(4):317-23. DOI: 10.1001/jamapediatrics.2014.3280. View

Nair P, Kee K, Mah C, Lee E . Evaluating the Impact of Outpatient Multi-Dose Medication Packaging Service (MDMPS) on Medication Adherence and Clinical Outcomes. J Prim Care Community Health. 2020; 11:2150132720965085. PMC: 7585883. DOI: 10.1177/2150132720965085. View

Kengne A, Briere J, Zhu L, Li J, Bhatia M, Atanasov P . Impact of poor medication adherence on clinical outcomes and health resource utilization in patients with hypertension and/or dyslipidemia: systematic review. Expert Rev Pharmacoecon Outcomes Res. 2023; 24(1):143-154. DOI: 10.1080/14737167.2023.2266135. View

Martell Claros N . Importance of adherence in the management of hypertension. Hipertens Riesgo Vasc. 2022; 40(1):34-39. DOI: 10.1016/j.hipert.2022.06.002. View

Moczygemba L, Barner J, Lawson K, Brown C, Gabrillo E, Godley P . Impact of telephone medication therapy management on medication and health-related problems, medication adherence, and Medicare Part D drug costs: a 6-month follow up. Am J Geriatr Pharmacother. 2011; 9(5):328-38. DOI: 10.1016/j.amjopharm.2011.08.001. View

Cecere L, Slatore C, Uman J, Evans L, Udris E, Bryson C . Adherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD). COPD. 2012; 9(3):251-8. DOI: 10.3109/15412555.2011.650241. View

Taylor A, Chen L, Smith M . Adherence to inhaled corticosteroids by asthmatic patients: measurement and modelling. Int J Clin Pharm. 2013; 36(1):112-9. PMC: 3885804. DOI: 10.1007/s11096-013-9862-0. View

Hernandez-Munoz J, Wong E, Kamdar C . Prevalence of statin utilization and adherence among privately insured subjects in the Commonwealth of Puerto Rico. J Manag Care Spec Pharm. 2021; 27(3):392-398. PMC: 10391102. DOI: 10.18553/jmcp.2021.27.3.392. View

10.

Yousif A, Lemiere C, Forget A, Beauchesne M, Blais L . Feasibility of implementing a web-based tool built from pharmacy claims data (e-MEDRESP) to monitor adherence to respiratory medications in primary care. Curr Med Res Opin. 2022; 38(12):2055-2067. DOI: 10.1080/03007995.2022.2135835. View

11.

Winslade N, Tamblyn R . Determinants of community pharmacists' quality of care: a population-based cohort study using pharmacy administrative claims data. BMJ Open. 2017; 7(9):e015877. PMC: 5623573. DOI: 10.1136/bmjopen-2017-015877. View

12.

Voorham J, Haaijer-Ruskamp F, Wolffenbuttel B, Stolk R, Denig P . Medication adherence affects treatment modifications in patients with type 2 diabetes. Clin Ther. 2011; 33(1):121-34. DOI: 10.1016/j.clinthera.2011.01.024. View

13.

Farmer A, Rodgers L, Lonergan M, Shields B, Weedon M, Donnelly L . Adherence to Oral Glucose-Lowering Therapies and Associations With 1-Year HbA1c: A Retrospective Cohort Analysis in a Large Primary Care Database. Diabetes Care. 2015; 39(2):258-263. PMC: 4894467. DOI: 10.2337/dc15-1194. View

14.

. Proceedings of the 3rd IPLeiria's International Health Congress : Leiria, Portugal. 6-7 May 2016. BMC Health Serv Res. 2016; 16 Suppl 3:200. PMC: 4943498. DOI: 10.1186/s12913-016-1423-5. View

15.

Stewart S, Moon Z, Horne R . Medication nonadherence: health impact, prevalence, correlates and interventions. Psychol Health. 2022; 38(6):726-765. DOI: 10.1080/08870446.2022.2144923. View

16.

Al-Hassany L, Kloosterboer S, Dierckx B, Koch B . Assessing methods of measuring medication adherence in chronically ill children-a narrative review. Patient Prefer Adherence. 2019; 13:1175-1189. PMC: 6660631. DOI: 10.2147/PPA.S200058. View

17.

Wolf M, Taitel M, Jiang J, Curtis L, Wismer G, Wallia A . Prevalence of Universal Medication Schedule prescribing and links to adherence. Am J Health Syst Pharm. 2020; 77(3):196-205. DOI: 10.1093/ajhp/zxz305. View

18.

Coelho A . Linkage between electronic prescribing data and pharmacy claims records to determine primary adherence: the case of antihypertensive therapy in the Lisbon and Tagus Valley Region, Portugal. Fam Pract. 2022; 40(2):248-254. DOI: 10.1093/fampra/cmac109. View

19.

Jung K, McBean A, Kim J . Comparison of statin adherence among beneficiaries in MA-PD plans versus PDPs. J Manag Care Pharm. 2012; 18(2):106-15. PMC: 10438047. DOI: 10.18553/jmcp.2012.18.2.106. View

20.

Hong M, Esse T, Vadhariya A, Gallardo E, Fosshat M, Mamvou J . Evaluating Success Factors of a Medication Adherence Tracker Pilot Program in Improving Part D Medication Adherence Metrics in a Medicare Advantage Plan: Importance of Provider Engagement. J Manag Care Spec Pharm. 2020; 26(5):662-667. PMC: 10391112. DOI: 10.18553/jmcp.2020.26.5.662. View